These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Natural cell-mediated resistance against Cryptococcus neoformans: a possible role for natural killer (NK) cells. Murphy JW Curr Top Med Mycol; 1985; 1():135-54. PubMed ID: 3916764 [No Abstract] [Full Text] [Related]
24. Lymphoproliferation and cytokine profiles in human peripheral blood mononuclear cells stimulated by Cryptococcus neoformans. Levitz SM; North EA J Med Vet Mycol; 1997; 35(4):229-36. PubMed ID: 9292418 [TBL] [Abstract][Full Text] [Related]
25. [Immuno-allergic assay with cryptococcin in police recruits of São Paulo (Brazil)]. Lacaz C; Melhem M Rev Hosp Clin Fac Med Sao Paulo; 1978 Feb; 33(1):49-51. PubMed ID: 351774 [No Abstract] [Full Text] [Related]
26. Kinetics of lymphocyte transformation in mice immunized with viable avirulent forms of Cryptococcus neoformans. Fromtling RA; Blackstock R; Hall NK; Bulmer GS Infect Immun; 1979 May; 24(2):449-53. PubMed ID: 378854 [TBL] [Abstract][Full Text] [Related]
27. Suppression of responses to cryptococcal antigen in murine cryptococcosis. Robinson BE; Hall NK; Bulmer GS; Blackstock R Mycopathologia; 1982 Dec; 80(3):157-63. PubMed ID: 6219291 [TBL] [Abstract][Full Text] [Related]
28. Non-specific immunosuppression by Cryptococcus neoformans infection. Blackstock R; Hall NK Mycopathologia; 1984 Apr; 86(1):35-43. PubMed ID: 6234468 [TBL] [Abstract][Full Text] [Related]
29. Cryptococcal meningitis; significance of positive antigen test on undiluted spinal fluid. Salom IL N Y State J Med; 1981 Aug; 81(9):1369-70. PubMed ID: 7022273 [No Abstract] [Full Text] [Related]
33. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus. Simark-Mattsson C; Jontell M; Bergenholtz G; Dahlgren UI J Dent Res; 1999 Nov; 78(11):1704-10. PubMed ID: 10576166 [TBL] [Abstract][Full Text] [Related]
35. Isolation of human fungi from soil and identification of two endemic areas of Cryptococcus neoformans and Coccidioides immitis. Rubinstein H; Marticorena B; Masih D; Borletto N; Vega R; Varengo H; Negroni R Rev Inst Med Trop Sao Paulo; 1989; 31(1):1-6. PubMed ID: 2682978 [TBL] [Abstract][Full Text] [Related]
36. Detection of antibodies to phospholipase B in patients infected with Cryptococcus neoformans by enzyme-linked immunosorbent assay (ELISA). Santangelo RT; Chen SC; Sorrell TC; Wright LC Med Mycol; 2005 Jun; 43(4):335-41. PubMed ID: 16110779 [TBL] [Abstract][Full Text] [Related]
37. In vitro effect of cyclosporine on interleukin-2 receptor expression stimulated by Cryptococcus neoformans. Miller GP; Lewis DE J Infect Dis; 1987 Apr; 155(4):799-802. PubMed ID: 3102632 [No Abstract] [Full Text] [Related]
38. Role of the latex agglutination test for cryptococcal antigen in diagnosing disseminated infections with Trichosporon beigelii. McManus EJ; Bozdech MJ; Jones JM J Infect Dis; 1985 Jun; 151(6):1167-9. PubMed ID: 3889173 [No Abstract] [Full Text] [Related]
39. Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity. Vecchiarelli A; Casadevall A Res Immunol; 1998; 149(4-5):321-33; discussion 500-3. PubMed ID: 9720950 [No Abstract] [Full Text] [Related]
40. Immunization of mice with a mutant of Cryptococcus neoformans. Characterization of the mutant, actively acquired resistance to experimental cryptococcosis in mice. Reiss F; Alture-Werber E Dermatologica; 1976; 152(1):16-22. PubMed ID: 780165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]